Clinical Trial Update: Study to Evaluate the Safety, Tolerability and Immunogenicity of Three Doses of GBS Vaccine in Elderly Participants [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating the safety, tolerability, and immunogenicity of three doses of a Group B Streptococcus vaccine in elderly participants has completed,…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Group Streptococcal Infections

Drugs mentioned

• GBS vaccine (Group B Streptococcus vaccine)

Snippet

Sponsor: Minervax ApS | Conditions: Group B Streptococcal Infections | Phase 1 | Status: COMPLETED | Results posted: 2025-09-05